Conference icon

Conference

The preventable burden of pneumococcal disease in the developing world.

Abstract:

The efficacy of pneumococcal conjugate vaccines (PCV) and their remarkable success in operational use in North America challenge us to define the burden of pneumococcal disease and the likely benefits of PCV use in developing countries. Community-based incidence studies of invasive pneumococcal disease (IPD) and vaccine probe analyses of efficacy trials suggest there are approximately 814,000 pneumococcal deaths in children aged <5 years in developing countries each year and 1-4 million ep...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Tropical Medicine
Role:
Author
Volume:
25
Issue:
13
Pages:
2398-2405
Publication date:
2007-03-05
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
URN:
uuid:26fd094b-beee-4758-891d-f3a7c3fc6956
Source identifiers:
72445
Local pid:
pubs:72445

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP